In this free webinar, learn the practical applications of precision motion approaches and sensor-enabled instrumented tests to measure performance outcome clinical outcome assessments for Parkinson's disease. Attendees will understand how performance outcome assessments of functional mobility can provide insights on the patient-reported Quality of Life impact and clinically meaningful outcome measures in Parkinson's disease trials. The featured speakers will discuss the selection and use of key imaging modalities and correlated clinical trial endpoints in Parkinson's Disease evaluation. The speakers will also discuss the considerations in device-generated data and analytics to support endpoint evaluation.
TORONTO, Aug. 30, 2022 /PRNewswire-PRWeb/ -- Register now to reserve your seat for this multidisciplinary virtual roundtable on advances in clinical trial endpoints collection for Parkinson's disease.
During this roundtable, a panel of clinicians and scientists will review advancements in imaging modalities and the expansion of wearable sensors for instrumented performance outcome, and the collection of digital clinical trial endpoints for Parkinson's disease trials. Examples will include how these approaches generate richer data and clinically meaningful outcomes in use cases to evaluate parameters such as disease progression and intervention efficacy. The featured speakers will discuss practical applications of precision motion sensor-based solutions to generate real-world data on patient functional mobility, and how it can influence patient's perception of Quality of Life & Activities of Daily Living impact.
In this webinar, the speakers will share clinical examples illustrating the selection and use of appropriate imaging studies and wearable sensors technology to capture performance outcome clinical outcome assessment (PerfO COA) in Parkinson's disease and related central nervous system conditions.
Join the speakers as they share their experiences and insights on the key aspects of selection and analysis in clinical trial endpoints, including recent US Food and Drug Administration Digital Health Technology (FDA DHT) guidance and Clinical consortia collaboration on digital outcome measures, data quality management and the expanding role of wearable technology devices in decentralized and hybrid trials.
Join Kristen Sowalsky, DC, PhD, Director Clinical Science and Consulting, Clario; Dr. Fay Horak, PT, PhD, Chief Scientist, Consulting, Clario; Martina Mancini, MS, PhD, PD KOL, Consulting, Clario; Diane Stephenson, PhD, Critical Path Institute; and Madhura Ingalhalikar, PhD, MRI Scientist, Neuro Medical Affairs, Clario, for the live webinar on Friday, September 23, 2022, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Advances in Precision Motion and Imaging Clinical Trial Endpoints Collection for Parkinson's Disease.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]